|drug3756||biological samples day of delivery Wiki||1.00|
|drug3701||Zinc Citrate Wiki||1.00|
|drug3633||Vitamin D3 Wiki||0.41|
There is one clinical trial.
COVID-19 is a global pandemic. So far encouraging results have been shown in different parts of the world with the utilisation of hydroxycloroquine, zinc, and azithromycin, and early studies into some of these, plus some with Vitamin C, have also proven beneficial. Vitamin D levels have also been shown to be an important indicator to the severity of symptoms in COVID-19 patients.
Description: Composite measure: Change in severity and duration of symptomsMeasure: Symptoms Time: once daily for 15 days since enrollment/baseline at admission to hospital
Description: total number of days in hospital since admissionMeasure: Length of hospital stay Time: at 15 and 45 days since admission/ enrolment
Description: need for invasive mechanical ventilation or mortality within 15 days from enrolmentMeasure: invasive mechanical ventilation or mortality Time: any time within 15 days from enrolment
Description: DeathMeasure: Mortality Time: 15 and 45 days since enrolment
Description: need for and number of days of invasive mechanical ventilation, in case of no need for mechanical ventilation: days=0Measure: mechanical ventilation Time: at 15 and 45 days since enrolment
Description: need for and number of days for humidified high-flow oxygenMeasure: oxygen Time: 15 and 45 days since enrolment
Description: admission to ICU (intensive care unit)Measure: ICU Time: 15 and 45 days since enrolment
Description: days in hospitalMeasure: days in hospital Time: 15 and 45 days since enrolment
Description: days in ICUMeasure: days in ICU Time: 15 and 45 days since enrolment
Description: need for and days of renal replacement therapyMeasure: renal replacement therapy Time: 15 and 45 days since enrolment
Description: need for and days of Extracorporeal supportMeasure: Extracorporeal support Time: 15 and 45 days since enrolment
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports